These are the two heavyweight weight-loss and diabetes medications, and people constantly ask which is better. They are different molecules with different mechanisms, and one generally produces more weight loss. Here is the full comparison.
Quick answer
Tirzepatide and semaglutide are both once-weekly injectable medications, but they are different drugs. Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual agonist that acts on two pathways (GIP and GLP-1). For weight loss, tirzepatide generally produced larger average weight loss in clinical trials, roughly 15% to 21% across doses, versus around 15% for semaglutide. Both share similar gastrointestinal side effects. Tirzepatide is often the stronger choice for weight loss, but the right one depends on your goals, tolerability, and cost.
The core difference: one pathway vs two
The defining distinction is mechanism.
- Semaglutide acts on a single receptor pathway: GLP-1. It mimics the GLP-1 hormone to reduce appetite, slow stomach emptying, and improve blood sugar.
- Tirzepatide acts on two pathways: GLP-1 and GIP. This dual action is thought to be why it tends to be more potent for weight loss.
They are not the same drug at different doses; they are genuinely different molecules. That is the foundation for every other difference.
Semaglutide vs tirzepatide: side-by-side
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GIP/GLP-1 receptor agonist |
| Dosing | Once weekly injection | Once weekly injection |
| Weight-loss brand | Wegovy | Zepbound |
| Diabetes brand | Ozempic (Rybelsus oral) | Mounjaro |
| Relative weight loss | High (~15% in trials) | Higher (~15-21% in trials) |
| Side effects | GI-dominant | GI-dominant |
| Cost | Often lower | Often higher |
Which causes more weight loss?
Tirzepatide, on average. In the trials of these drug classes, tirzepatide (the SURMOUNT program) produced average weight loss roughly in the 15% to 21% range across doses at about 72 weeks, while semaglutide (the STEP program) produced around 15% at about 68 weeks. So tirzepatide generally has the edge for maximum weight loss.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →That said, "on average" matters. Individual results vary widely. Some people do exceptionally well on semaglutide, and semaglutide's results are still substantial and well established. Tirzepatide leads the averages, but it is not the only effective option.
Do they work faster?
Both build their effect gradually as you titrate up through the dose schedule, so neither is an overnight switch. Tirzepatide's greater potency can mean more noticeable results as you reach higher doses, but both require patience through the early titration weeks. Judging either by the first month or two underestimates them, since the larger results accumulate over many months.
Side effects: are they different?
Not meaningfully. Both share the GLP-1 class side-effect profile, led by gastrointestinal symptoms: nausea, vomiting, diarrhea, and constipation, worst during dose increases. There is no reliable evidence that one is uniformly gentler than the other; head-to-head diabetes data showed broadly comparable tolerability. Individual experience varies, which is why some people who cannot tolerate one do fine on the other.
Cost and availability
Tirzepatide is often more expensive than semaglutide, and pricing, insurance coverage, and availability differ between them. Coverage also depends on the indication: the diabetes products (Ozempic, Mounjaro) and the weight products (Wegovy, Zepbound) have different coverage situations. For many people, cost and access shape the real-world decision as much as potency.
Which should you choose?
- Maximum weight loss is the priority: tirzepatide generally leads.
- You want a well-established option, possibly at lower cost: semaglutide is a strong, proven choice.
- Tolerability is a concern: both are similar; individual response varies, and switching is possible.
- Cost and coverage matter most: compare the specific products and your insurance.
The decision belongs with a licensed prescriber who weighs your goals, health, tolerability, and budget. For people pursuing weight management, FormBlends offers compounded semaglutide through licensed prescribers and a provider comparison tool to compare options side by side.
Frequently asked questions
Is tirzepatide better than semaglutide? For weight loss, tirzepatide generally produced larger average weight loss in trials. But both are effective, and the best choice depends on your goals, tolerability, and cost.
What is the difference between semaglutide and tirzepatide? Semaglutide acts on one pathway (GLP-1); tirzepatide acts on two (GIP and GLP-1). They are different molecules, not the same drug at different doses.
Does tirzepatide or semaglutide work faster? Both build effect gradually through dose titration. Neither is instant. Tirzepatide's greater potency can show more as you reach higher doses.
Does tirzepatide have fewer side effects than semaglutide? Not reliably. Both share GI-dominant side effects, and head-to-head data showed broadly comparable tolerability. Individual response varies.
Is tirzepatide more expensive than semaglutide? Often, yes. Pricing, coverage, and availability differ between them and between their diabetes and weight-loss products.
Are they the same drug? No. They are different molecules with different mechanisms, sold under different brand names.
Can I switch between them? Some people switch, often due to tolerability or response. This is a decision to make with your prescriber.
Sources
- New England Journal of Medicine, SURMOUNT-1 (tirzepatide) and STEP 1 (semaglutide) obesity trials - https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
- New England Journal of Medicine, SURPASS-2: Tirzepatide versus Semaglutide in Type 2 Diabetes - https://www.nejm.org/doi/full/10.1056/NEJMoa2107519
